Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)

Published on 22 Mar 2024 on GuruFocus.com via Yahoo Finance

Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)

Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), has sold 18,235 shares of the company on March 21, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $40.34 per share, resulting in a total value of $735,799.90.

Warning! GuruFocus has detected 3 Warning Signs with RYTM.

Read the rest of the article

NASDAQ.RYTM price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Earnings call: Rhythm Pharmaceuticals has reported a successful third quarter in...

Rhythm Pharmaceuticals, Inc. (NASDAQ: NASDAQ:RYTM) has reported a successful third quarter in 202...

Investing.com 6 Nov 2024

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong...

Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

iRobot cuts 105 jobs as part of 'operational restructuring plan' - Boston...

IRobot Corp. is making additional cuts as it tries to get its business back on track after the...

The Business Journals 5 Nov 2024

Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish

We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers...

Insider Monkey · via Yahoo Finance 22 Sep 2024

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $2.35 per share versus the ...

Zacks via Yahoo Finance 7 May 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript May 7, 2024 Rhythm Ph...

Insider Monkey via Yahoo Finance 5 May 2024

Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is possibly approaching a major achievement in its bus...

Simply Wall St. via Yahoo Finance 14 Apr 2024

Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)

Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), has sold 18,...

GuruFocus.com via Yahoo Finance 22 Mar 2024

Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 20 Mar 2024

Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 20 Mar 2024

News

Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)

NASDAQ.RYTM price evolution

Want to become a better investor?